Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JBX is a prominent Australian healthcare company primarily known for its flagship brand, Bio Island, which specializes in premium family nutrition and wellbeing products. Founded in 2008 and based in Sydney, the company develops and supplies a wide range of vitamins and nutritional supplements tailored for infants, children, pregnant women, and adults. JBX's products are manufactured locally in Australia and are regulated as complementary medicines under the Therapeutic Goods Administration (TGA) framework. The company has established a significant international presence, particularly in Southeast Asia and China, where it is a leading brand in the maternal and child nutrition sector. With consolidated annual revenue exceeding $100 million, JBX continues to focus on high-quality ingredient sourcing and innovative formulations to support long-term family health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JBX.